Apr22

Pharmacists — New Agents of Change for Improved Healthcare Delivery?

pharmacist and customerIt is becoming increasingly common to encounter new outlets for healthcare delivery within retail pharmacies, big box stores, supermarkets, etc. This phenomenon is not occurring by happenstance. We often hear there is a growing shortage of physicians, nurses and other healthcare professionals. Now, this shortage is likely to be magnified by the large number of newly insured patients entering the market as a result of the Affordable Care Act. These patients will need new places to seek care and new types of healthcare professionals to care for them.

One site of care that is becoming an increasingly attractive destination for patients is the retail clinic, due to the convenience and quality of service for basic healthcare needs. When we examine the average cost of a minor illness visit across different sites of care, we see that retail clinics provide a viable and cost-effective alternative:

  • Retail clinic: $76
  • Physician visit: $120
  • Urgent care: $121
  • Emergency room: $499

Given the reduced burden on the system, we can expect that healthcare delivery will continue to migrate outside of traditional physician and hospital channels, to non-traditional, lower-cost venues like retail clinics. In fact, the number of retail clinics is estimated to grow 25% to 30% annually to almost 2,900 by 2015. But who is primarily responsible for providing care in these locations?

Most often it is pharmacists who play a very active role in delivering care. They have expanded their role beyond drug dispensing to include medication reviews, providing education materials, administering vaccinations, and more.  Furthermore, they are well-positioned to continue to expand their influence on patient care.

As marketers, we should closely examine the potential role pharmacy could play to improve the quality and cost efficiency of healthcare delivery. As one of the key patient-facing allied healthcare professionals, they should be supported with education and tools that go far beyond their traditional focus on drug dosing and dispensing. Pharmacists have training and access to data that uniquely position them to help improve the patient’s journey from the first prescription after diagnosis, through ongoing adherent treatment, to chronic disease management and/or recovery.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Affordable Care Act, Education, Health & Wellness, Medicine, Pharmaceutical | Tagged , , , , , | Leave a comment
Apr17

Multi-Screen Is the New “Mobile First”

screensFor the past few years, “Mobile first!” has been the rally cry of marketers. The idea was to design websites and ads to work on mobile devices first to account for the growing smartphone- and tablet-using audience. But mobile first is already obsolete; if your strategy doesn’t have multiple screens in mind, then your strategy is out-of-date.

Time spent on mobile devices is steadily increasing. Throughout the day, consumers are moving seamlessly back and forth between many devices, from laptops to smartphones to tablets to TVs. In fact, 90% of consumers start a task on one device and finish it on another. Oftentimes consumers are using more than one device at a time, fluidly flipping back and forth between screens.

This complexity in user behavior makes it imperative for marketers to embrace a multi-device strategy, not just a mobile-first one.

You must now develop ads that work across these multiple devices. The ads should seamlessly leverage the characteristics of each device for optimal user experience. Additionally, where consumers used to be focused on one device at a time, now they are on multiple devices simultaneously, so messaging needs to adapt to the multi-device paradigm as well.

Consumer search trends support the need for multi-screen advertising. According to eMarketer, U.S. mobile search ad spending grew 120.8% in 2013, contributing to an overall gain of 122.0% for all mobile ads. Meanwhile, overall desktop ad spending increased just 2.3% last year. Marketers should not only develop ads for multiple platforms, they should optimize their spending across platforms as well.

Ad targeting also becomes paramount in the multi-screen world. Targeting ads to specific devices and operating systems is the most basic method of mobile ad targeting. But much like the desktop environment, user insights can be culled from the type of content consumed on tablets and smartphones. These insights can then be used to further target mobile audiences.

As consumers continue to access content across multiple devices, marketers must continue to grow and change with them to meet their needs no matter which device(s) they are using.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, content marketing, Content Strategy, Creativity, Data, Digital, Digital Advertising, Media, Multi Channel Marketing, Strategy, Technology | Tagged , , , , | Leave a comment
Apr10

The Cycle of DTC

blueskyThe history of DTC advertising (and by that I mean all consumer/patient outreach, not just TV), has seen a number of highs and lows over the years.

When campaigns first launched in the late ’90s and early 2000s, we watched as pharma marketers and their agencies worked to create brands out of medicines that, quite frankly, most users didn’t really want to have a relationship with.

During that time, we watched as Claritin and later Clarinex integrated graphics and special effects into their messages; we were introduced to critters including the Zoloft blob and Digger; we applauded the uniqueness of Vytorin’s “food & family” representation of the 2 sources of cholesterol. The Lunesta moth was heralded as iconic, while some of us scratched our heads over the story of Abe & the beaver as told by Rozerem.

The list goes on and on…. The point being, these were campaigns that sparked a reaction (good and bad), told a story, leveraged an insight, and by most accounts, helped our clients successfully market their drugs.

By the late 2000s, many of us noticed a perceptible shift in pharmaceutical campaigns. Some of this was coincident with a number of significant safety issues that prompted some of the major advertisers to pull back, and as more and more companies sought to “preclear” their ads through DDMAC and then OPDP, the feedback, in many cases in my experience, resulted in campaigns that while still engaging on some levels appeared to stop just short of eliciting any kind of emotion or reaction (again, good or bad). Our work still resulted in positive ROIs, it still won awards, but it just wasn’t the type of work that had people talking.

I’m happy to say that lately, the tide seems to be turning. Recent advertising for Crestor reinforces a positive brand experience by literally depicting a patient as a fan. A fairly light-hearted approach that still seems appropriate and responsible, still depicts the risks and benefits in a balanced manner, but one that evokes an emotional reaction, and presumably for Crestor users present and future, a connection with the brand. And campaigns like Novartis’ Gilenya illustrate how a brand can connect with patients—literally and figuratively.

Another positive outcome of this shift back to more emotive and insightful DTC appears to be a resurgence of more disease education. These campaigns are not only getting people to the doctor for appropriate medical advice and care, they are inspiring conversations and connections. Gilead’s “Full Frontal” campaign is provocative and buzz-worthy on the basis of its name alone…but the drama of the idea coupled with the real patient stories just increases the emotional impact and call to action.

So the next time a DTC ad turns up on your TV or Facebook feed…don’t skip it…you might be pleasantly surprised that DTC is back!

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, Creativity, Direct-to-Consumer, Media, Personal Reflections | Tagged , , , , | Leave a comment
Apr3

Benefits of Rich Media

The digital pharmaceutical advertising market is proving to be a growing and changing market.  Gradually over the past couple of years, more innovative tactics have become more relevant. Rich media is one tactic that has become more widely accepted not only by pharma companies and advertisers, but also by publishers. Some of you may be asking, what is rich media and why is it becoming more popular?

Rich Media Banner—This is an ad that can contain images and/or video and involves some kind of user interaction which can elicit strong user response. The ads can include multiple levels of content in one placement.

what_is_rich_media_small

 

 

The benefits of using rich media:

Ads Expand—The creative expands when the user interacts with the main image (for example, by clicking or mousing over it). This allows for a larger area to display more robust information, creative artwork and messaging while still being able to include a scrolling ISI and creative assets (videos, clinical data, polls/surveys, etc).

Breaks Through Banner Blindness—Banner blindness is a phenomenon in web usability where visitors to a website consciously or subconsciously ignore banner-like information, which can also be called ad blindness or banner noise. Rich media ads are more attention-grabbing and interactive, which helps separate them from being banner-like. Rich media banners also have proven to outperform standard display banners in key metrics such as time spent and interaction rate.

Information—Rich media banners can contain a significant amount of information, especially compared to standard display ads. This information can consist of videos, charts, clinical data, polls/surveys, or multiple creative messages. This allows advertisers to reach a larger target audience while also providing more options for multi-indication brands in one banner ad.

Metrics—The metrics in rich media banners are also greatly improved. Rich media offers standard metrics and also custom metrics. Standard metrics are more commonly known and consist of metrics like total display time, number of expansions, interactive impressions, and interactive rate. Custom metrics are added to components within a rich media banner, and only three different types are used: exits, counters and timer. These custom metrics can actually track a variety of calls to action within a rich media banner, like links within the banner, time spent on certain screens or data, and of course any click-through calls to action. These robust metrics offer a huge advantage over standard display banners which rely heavily on impressions and clicks.

User Experience—Overall user experience is improved through the use of rich media. The creative messaging can be so robust within a rich media banner that a call to action such as a click-through is not required. This actually allows users to stay on the same page where they saw the rich media banner, as opposed to clicking on a non-rich media banner that takes them to an entirely new page.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, Analytics, Data, Design, Digital, Digital Advertising, Media, rich media, Strategy, Technology | Tagged , , , , | Leave a comment
Apr1

Knowledge Management

knowledge is powerIgnoring the fact that Australia is a very long way from the UK and that I have an intense fear of spiders, snakes and sharks, I recently took a trip Down Under.  My Aussie mates (actually mostly British ex-pats but all of whom have developed that distinct accent of turning every statement into a question) persuaded me I was due a visit. Admittedly, I hadn’t needed much convincing, with the reminder that the food is delicious, the beer is cold and the sun nearly always shines.

My first few days in Sydney were easily occupied with zipping around the city on the superb ferry network, photographing sharks in the impressive aquarium, and seizing the opportunity to swim in the ocean. Having left behind a rather soggy Britain, it was heavenly to be in the sunshine with flip-flops (or “thongs” to our Australia colleagues) on my feet and no need for a warm coat or an umbrella.

Midway through my trip, I had arranged to visit Ogilvy CommonHealth in Sydney to meet with Muriel Wang. Along with David Chapman, Muriel and I form a global team dedicated to the management of knowledge, called Global Knowledge Management.

What is knowledge management and why is it important? Knowledge is a key asset for any organisation, but in our knowledge-intensive world, it is necessary to be able to cut through the noise. Knowledge management is the process of capturing, organising, sharing and effectively using organisational knowledge.

Obviously the starting point for knowledge is data. Whilst data can be easily stored, knowledge, intelligence, learning and wisdom reside in the heads of people. A sustainable knowledge management strategy creates an organisational memory, reducing the loss of know-how.

The value of knowledge management is better and faster decisions; by tapping into the experience of your colleagues around the world, you can avoid their mistakes, apply their solutions and make the right decision the first time. This is evidenced in our support of new business efforts, and as Muriel explained, “This is particularly relevant in Asia Pac, where products often launch later than in the US and Europe. Being able to learn from the experience of our global colleagues helps us to get a leg up on our competition, so to speak.”

In addition to improved decisions from facilitated access to expertise, knowledge management reduces “reinventing the wheel” and prevents loss of knowledge from changes in organisational structure and staff turnover. Client, brand and therapy experience can easily be forgotten if not documented, and our capture of this data into databases is proving invaluable in responding quickly to internal and external requests.

Knowledge management requires a collaborative culture and a shift from “I know” and “knowledge is owned” to “we know” and “knowledge is shared.” Global Knowledge Management meets regularly to share insights from each of our regions, and taking a brief interlude from my trip to Oz to pop into the Sydney office and meet with Muriel will no doubt enhance our global knowledge management collaboration going forward.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Data, Efficacy, knowledge management, Learning | Tagged , , , | Leave a comment
Mar25

SXSW 2014: True Potential of Social Media in Healthcare Is Still Ahead of Us

sxsw logoOver a single-week period, SXSW Interactive hosts hundreds of presentations and panels. What was interesting to note this year, compared to the last few, is that a large percentage of healthcare discussions were now hosted on the stages of the two main convention centers, alongside all major celebrity keynotes.

Among many trends and ideas that were discussed, two concepts mentioned at the “What Happens When Tech and Healthcare Meet” panel were quite memorable. Although these are just mere single examples, each testified to a number of current trends in healthcare.

Concept: DermLink—a social network-based platform that allows patients to digitally share skin conditions with dermatologists and receive real-time responses.

Why this is important: This is especially relevant to those outside major metropolitan areas, where a wait to see the local dermatologist can exceed a few weeks. We’ve all heard success stories of doctors tapping into a broad pool of peers via Twitter and Facebook. But this platform is among the first controlled, social, care-specific environments that could potentially redefine the approach and expectations for doctor-patient interaction.

Bottom line: Regardless of the success of this platform, the mere fact that this platform is gaining momentum is an indicator that the true potential of social media in healthcare is still ahead of us.

Concept: Covered—a platform that helps applicants select the most appropriate health insurance by posing a series of qualifying questions in a standard, conversational language.

Why this is important: Although standard applications have been around for quite some time, we’re starting to see a shift in the way even insurance companies need to structure their communications. Over the past decade, we’ve witnessed a similar shift in practically every single aspect of marketing communication etiquette due to social media. A simple, well-timed response to a tweet can gain greater consumer loyalty than a multimillion-dollar Super Bowl ad.

Bottom line: Consumers no longer want to be talked at. They want to be spoken with. This is no longer breaking news…rather, a well-known fact. But at last it is finally beginning to change the insurance companies’ tone of interaction with potential applicants.

SXSW Series:

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Apps, Data, Digital, Physician Communications, Social Media, SXSW, SXSW Interactive, Technology | Tagged , , , , , , , , , | Leave a comment
Mar21

The Future of Wearables at SXSW 2014

SXSW_Logo_2013_BlackBG_CSAs you might have imagined, the conversation around wearables was booming at SXSW this year.  But they weren’t talking about FitBit or Fuelband as you might expect.  They were talking about what comes next, after we’ve quantified our surface vitals.

“I got bored with how many steps I walked every day and quickly got used to the idea that I was never doing enough,” said Tim Brown, CEO of IDEO, in a conversation-style session held with Joi Ito, Director of the MIT Media Lab.  “The amount we are starting to wear to track our vital signs is crazy, but we are moving beyond vitals very quickly,” Brown went on.

The Affective Computing group at MIT is now taking wearables deeper into ourselves than ever before with conductive skin technologies that can detect stress and, paired with complex algorithms, intuit emotions. In aggregate, Joi explained, this will grant us the ability to curate our lives in ways we couldn’t before.  Historically, our environment and circumstances were akin to a series of accidents and coincidences. The future will be much more intentional.

In the healthcare delivery space, these new technologies will help us treat and understand emotional conditions like anxiety, stress, autism, and others. “Devices like Neumitra will transform the way we think about mental health,” said Scott Stropkay, co-founder of Essential. “Mental health is about brain health, which is analogous to physical health, which can be measured and improved.”

Technologies like Neuma, a bio-sensing watch, help measure stress in real time so we can start to manage it.  Linked to a dashboard and combined with calendars or locations, we can begin to figure out what stresses us out—and what calms us. On a larger scale, we can aggregate that data to help make our communities, societies, and world an altogether less-stressful place.

But there is a moral question to all this measurement and quantification. Sometimes there are evolutionary and societal reasons for the need to deceive ourselves. After a less-than-savory meal at a friend’s house, we are conditioned to say, “dinner was great,” so as not to offend. And we are conditioned to believe it. “What’s interesting,” says Ito, “is that the subconscious always knows, we just don’t always rationalize. In a controlled, unemotional study, we can pick out the liar.”

Emotion- and stress-tracking wearables bring the sub-conscious truth about ourselves to the surface.  And how will these affect things like healthcare?  We are all familiar with the placebo affect, which works both ways. This, in fact, is the basis for the FDA ordering 23andMe, an online genetic testing service that provides ancestry-related genetic reports, to cease providing health-related reports until the FDA works through the implications and figures out how to regulate this new kind of service. “Nine out of 10 cases of type 2 diabetes can be prevented. But we spend more money treating than we do preventing,” said Ann Wojcicki, founder of 23andMe. “Everyone makes money when I am sick, but who makes money when I am healthy?”

“Twenty-seven percent of us are wearing some sort of sensor,” explained Dr. Leslie Saxon while speaking on Body Computing. “A new person—from birth until the time they are two—will have more medical record data stored in the cloud than any person who came before them.”

All of this is leading to a new kind of personalized healthcare. The kind of healthcare in which delivery mechanisms happen in real-time and enable informed decision-making.  At an aggregate level, data can aid, inform, and expedite research.

Today’s quantified wearables are a great start, but the future of wearables is contextual, environmental shaping, and behavior changing.

SXSW Series:

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in behavior change, Data, Digital, SXSW, Wearable Health Technology | Tagged , , , , , | 2 Responses
Mar20

The Best of SXSW 2014

sxsw logoI could give you a top 10 list or a top 5 list of what was best at SXSW. That would be great if I were trying to convince you of why attending SXSW is an amazing learning experience. However, what I’d like to provide is the best single thing I learned, and get into some actionable details.

So, I was ready to get into what seemed to be a great talk. I was on line waiting, about a dozen people away from the door, when I heard, “Sorry, this session is full.” So with that news I went next door and found a talk titled, “Let’s Get Physical—Design + Embodied Cognition,” by Michael Hendrix, Partner and Creative Director at IDEO. By chance, I’d just found what was to me the best talk of SXSW.

Embodied cognition is the theory that the human mind is largely determined by the form of the human body. To simplify, the mind is experiencing the world through all our senses. The more senses that are stimulated, the more powerful the experience.

The really interesting part of this is that our minds cannot really differentiate a real experience from an imagined one. For example, when we go to the movies and experience an action-packed film, we are experiencing intense visual and aural senses. Our reaction to this fabricated experience is that we may be sitting forward in our seat, our heart rate may increase and the palms of our hands may even sweat. Our minds are telling our bodies to react to the imaginary experience as though it’s real. This is powerful stuff. The more senses we engage in an experience, the more our minds take that experience in and make it memorable.

Brands are already using this principle to design their products to convey a certain aesthetic to potential buyers. One example provided at the SXSW session was that BMW makes the hinges on their car doors heavier to convey quality and safety. People who are looking to buy a car will place a premium on a safe, well-built car.

So how does this apply to our world of marketing? Well, let’s say we are creating an iPad piece for sales reps to detail to doctors. It is common for these to include some basic ways of swiping or tapping to navigate to content. Additionally, it is the sales rep who is usually using the device. However, if we want to make this experience memorable for doctors, we should put the device in their hands and tap into more of their senses. We should think about including interesting visual and audio content. Additionally, we can use the interactive capabilities of the iPad to engage even more of the senses. For example, the iPad will recognize with its built-in gyroscope if it’s tilted or moved in a three-dimensional space, with its motion sensor if it’s shaken, or with its multi-touch screen if it’s touched with multiple fingers.

This may sound like fun and games or interaction for interaction’s sake but there is real scientific research that backs up communicating this way. The more we can tap into human senses when we communicate, the more powerful and memorable the communication will be. And remember, that goes for real and imagined experiences. This is an idea that can breathe new life into the way we think about our clients’ needs.

SXSW Series:

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in Digital, Media, Physician Communications, SXSW, Technology | Tagged , , , , , | Leave a comment
Mar11

SXSW 2014: Technology and Health

SXSW_Logo_2013_BlackBG_CS

In Part 1 of his SXSW blog series, Robert Egert recaps some of the SXSW themes that are transforming the way the world looks at healthcare.

Massive—that’s the first thing you need to understand about the SXSW experience. At any given time, there are 30 to 50 events to choose from taking place in multiple locations throughout downtown Austin. This means that, unlike conventional conferences, each individual attendee cuts his or her own path through the events by selecting and reselecting from the nearly unmanageable array of keynotes, panel discussions, presentations, and workshops.

Events that feature celebrity speakers or that focus on hot topics can fill up quickly. Dashing from event to event, waiting in long lines, and striking up random conversations en route is part of the experience. Many events include audience QA, so if it suits your fancy you can become part of the public conversation, even if you aren’t an official presenter.

Here’s a highly personal recap of the themes, issues, and events that impressed, stimulated, and/or frightened me:

BIOMETRICS

The Idea: The pervasive collection of quantified biometric data will transform healthcare.

Wearable, implanted, and otherwise applied technologies will collect vast amounts of data on each of us throughout the day and night regardless of where we are or what we are doing. The collected data won’t only be sent to our phones—it will also be shared with physicians and aggregated into an ever-expanding library of health data.

This library can be used to evaluate the impacts of lifestyle choices on health and longevity (how much of what kinds of exercise must you do to reduce hypertension?). They can also measure the impact of pharmacologic therapies (which drug was more effective?), they can help identify disease patterns (what patterns around comorbidity should be looked at?), and they can provide real-time reports on just about anything you want to know about human behavior and health.

Why this is important:

If we combine biometrics with the predictive capabilities of DNA analysis, we’ll be able to obtain a detailed image of our individual health within the larger social context.

CROWD-SOURCED DRUG DISCOVERY

The Idea: Crowd-sourcing health studies and clinical trials.

Current approaches to drug testing and conducting health studies are expensive, slow, and cumbersome. What if we used crowd-sourcing to answer quantifiable health questions?

Jessica Richman, who is the founder of uBiome, a start-up that uses a crowd-sourced approach to collecting scientific health data, proposes that we dramatically change our approach to scientific inquiry. She suggests that with the right protocols and infrastructure in place, crowd-sourcing will be used to speed the evaluation of new products, measure the effectiveness and safety of products already in-market, and obtain quantifiable data on the health impacts of lifestyle choices.

This approach promises to allow us to quickly and efficiently collect larger data sets than ever before. But with this comes the responsibility to maintain processes and checks to maintain scientific integrity.

Why this is important:

It can dramatically reduce the cost of conducting health and drug studies, and it can generate libraries of data for ad hoc inquiry and analysis.

SXSW Series:

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in clinical trials, Data, Health & Wellness, Pharmaceutical, Science, SXSW | Tagged , , , , , , | Leave a comment
Mar6

The Power of Payer: Prescribe All You Want…We Can Block You!

6808124Remember the Doritos slogan, “Crunch all you want, we’ll make more!”? What a mantra, supply and demand. So simple. So obvious.

Sure, prescriber demand plays a role in how available some drugs are, but at the end of the day health plans and formulary P&T committees within hospitals and large practices make category decisions that effect drug availability for patients and directly impact prescribing behavior. These formulary decisions aren’t made in a vacuum, and they can impact your brands, your marketing goals, and play a huge role in getting a leg up in today’s market.

So what do you know about all this? If your client came to you tomorrow in a competitive market situation—multiple new branded entrants, generic domination, or patient abandonment at the pharmacy—and they couldn’t get a foothold, what would you tell them? How would you break that wall? How do you partner with your clients to fulfill your brand’s true market destiny?

Consider what the payer marketing unit can bring to the table for you and your clients. More and more we hear our clients talk about access challenges broadly, issues with patient co-pays, or prior authorizations and step edits getting in the way of reaching marketing goals. In this changing healthcare environment there is so much to consider that plays a role in prescriber decision making, it goes well beyond the clinical profile of your brand. The smarter we all are regarding the holistic considerations of a brand, the better we can show our value as a marketing partner and offer uniquely impactful solutions to our clients.insurances

This is where the Power of Payer comes in. The payer marketing units at Ogilvy CommonHealth Worldwide want to help provide you with a strong background on health plan and environmental issues to more effectively reach your client’s marketing goals. We are actively working towards open house events for Ogilvy CommonHealth Worldwide in NJ and NY where we can share information specific to two hot topics:

  • Emerging healthcare models: What are they? How do they hold the keys to success in the market? What should we know about them? Better understand how they act and what these actions mean to our clients and their brands.
  • Payer for newbies: An overview of what a payer is. Who are payer customers and manufacturer clients? How do payer decisions impact overall market sales goals and category usage? Why do we need to consider them when building brand plans and overcoming marketing hurdles?

"Open House” Posting. Part of our “Create a Sign” Series.As part of the Power of Payer open houses, we will also showcase some of the unique work we have done to achieve market success as well as answer any questions you may have about the payer customer, unique challenges your brand may be facing, or just have a fun discussion around environmental trends!

Watch for more information and then mark your calendars to join us for the Power of Payer open houses.

CONTINUE THE CONVERSATION: Questions? Comments? You can contact the author directly at blog@ochww.com. Please allow 24 hours for response.

Also posted in Access, Branding, Clients, Managed Care, Marketing, Reimbursement | Tagged , , , , , , | Leave a comment